[Strategy for patients with low-risk coronary artery disease: initial medical therapy only or PCI plus medical...

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Trials

Context:

• Stable low-risk coronary artery disease (CAD) requires effective long-term management strategies.
• The optimal treatment approach, balancing percutaneous coronary intervention (PCI) with medical therapy versus medical therapy alone, remains an area of investigation.
• Previous trials like the COURAGE trial have provided valuable insights but further research is needed for specific patient populations.

Purpose:

• To compare the long-term prognoses of percutaneous coronary intervention (PCI) plus medical therapy (P) versus medical therapy (M) alone in patients with stable low-risk coronary artery disease (CAD).
• To evaluate the effectiveness of PCI in reducing the cumulative risk of death and acute coronary syndrome (ACS).
• To investigate the incidence of ACS originating from PCI-target lesions.

Summary:

• A randomized trial (JSAP Study) compared PCI plus medical therapy (P) with medical therapy alone (M) in stable low-risk CAD patients.
• The cumulative risk of death plus ACS was significantly lower in the PCI group (P).
• The incidence of ACS originating from the PCI-target lesion was also significantly lower in the PCI group.

Impact:

• PCI therapy may offer improved long-term prognosis in stable low-risk CAD by stabilizing target lesions and reducing stenosis, potentially preventing future ACS events.
• These findings suggest PCI could be a more effective strategy than medical therapy alone for certain CAD patients, contrasting with some previous trial outcomes.
• The study highlights the importance of considering lesion stabilization and stenosis reduction as mechanisms for improved outcomes in CAD management.